Endo Announces Early Termination of HSR Act Waiting Period in Connection with Its Proposed Acquisition of Paladin Labs

Endo Health Solutions (NASDAQ: ENDP ) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act") in connection with Endo's proposed acquisition of Paladin Labs Inc. (TSX: PLB) ("Paladin Labs") was terminated by the United States Federal Trade Commission on December